SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Activity

233 hedge funds and large institutions have $1.59B invested in Supernus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
+11
Holders Change %
+4.95%
% of All Funds
3.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
90
Reduced
67
Closed
28
Calls
$2.84M
Puts
$3.95M
Net Calls
-$1.11M
Net Calls Change
-$6.27M

Top Buyers

1
SIMG
Stephens Investment Management Group
Texas
$46M
2
LCG
Lisanti Capital Growth
New York
$8.88M
3
AC
Armistice Capital
New York
$121M
4
GKIM
GW&K Investment Management
Massachusetts
$53.6M
5
Federated Hermes
Federated Hermes
Pennsylvania
$3.86M

Top Sellers

1
BlackRock
BlackRock
New York
$246M
2
Millennium Management
Millennium Management
New York
$2.67M
3
HP
HealthInvest Partners
Sweden
$0
4
Invesco
Invesco
Georgia
$21.7M
5
Renaissance Technologies
Renaissance Technologies
New York
$36.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
SMA
251
Sage Mountain Advisors
Georgia
– -$15K -574 Closed
LWM
252
Liberty Wealth Management
California
– -$9K -326 Closed
CFD
253
Creative Financial Designs
Indiana
– -$8K -297 Closed
MAM
254
Meeder Asset Management
Ohio
– -$8K -292 Closed
JG
255
Jefferies Group
New York
– -$2.67K -100 Closed
CFA
256
Carroll Financial Associates
North Carolina
– -$1K -56 Closed
DWP
257
Destiny Wealth Partners
Florida
– -$1K -29 Closed
7 8 9 10
11